Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Patients 20 & 21

<< Previous

Bullboard Posts

Next >>

Post by 99942Apophison Jun 10, 2022 11:10am

327 Views

Post# 34747094

Patients 20 & 21

Patient 20 announced June 11/2021 just hit 360 days and although patients 21 to 24 were announced August 30/2021 my guesstimate is patient 21 will hit 360 days very close to the AGM.
By years end (2022) we should see 24 patients hitting 450 days with a strong possibility of patient 25 getting in too.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec